$ATEC

Marshall Tyson Eliot sold $79K of ATEC

Marshall Tyson Eliot (GENERAL COUNSEL & CORP. SEC.) sold 8,168 shares of Alphatec Holdings, Inc. (ATEC) at $9.65 on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Marshall Tyson Eliot
Published Aug 8, 2026, 12:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 8, 2026, 12:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATEC
Neutral
high confidence
Mentioned
$ATEC
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATECNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity but does not include any new company fundamentals, guidance, or regulatory/operational developments.

02

Market read

Traders may treat this as low-signal sentiment information rather than a catalyst.

03

What to watch

The article does not state whether the sale was part of a larger series, nor does it provide context on total insider holdings changes beyond the post-transaction share count.

Relevance 2/10Novelty 3/10Timing: Form 4 filed 2026-08-07 for a sale executed 2026-08-05

Background

The article is an SEC Form 4 insider transaction disclosure for Alphatec Holdings, Inc.

Company-level read

Ticker impact

$ATECNeutralHigh confidence
Context

Alphatec Holdings insider Marshall Tyson Eliot filed a Form 4 selling 8,168 shares at $9.65 on 2026-08-05 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing specifies an open-market sale under a pre-arranged Rule 10b5-1 plan, with no accompanying company news, contract, or guidance change.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with insider expectations of near-term risk, so traders may still watch for follow-on selling or other filings.

Key entities

  • Alphatec Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Marshall Tyson Eliot

    General Counsel and corporate SEC officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

$ATECMedAI 8/10

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.